Global Dialysis

Dialysis industry news

Stories from the dialysis comunity across the globe.

ASN Kidney News - Kidney Week edition

ASN: Here is the ASN Kidney News summary of the annual meeting.

...

American Heart Association Scientific Sessions 2012 News - Sunday

AHA: The sessions news is published daily. This is the second day summary.

...

American Heart Association Scientific Sessions 2012 News - Saturday

AHA: The sessions news is published daily. This is the first day summary.

...

Nabilone shows benefits in managing pain of diabetic neuropathy.

Science Blog: A study from the University of Calgary’s Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week placebo controlled clinical study. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone as compared to the placebo.

...

Eculizumab for atypical HUS shows promise on longer term treatment.

Daily Finance: The data demonstrated that ongoing Soliris treatment for two years was associated with sustained inhibition of complement-mediated TMA, as indicated by a maintained increase in platelet count, and sustained improvement in renal function and TMA event-free status. The data were presented today at Kidney Week 2012, the annual meeting of the American Society of Nephrology (ASN) in San Diego. Additionally, data presented in a poster session at ASN support early initiation of Soliris therapy regardless of the presence or absence of genetic mutations in patients with aHUS.

...

More Articles...

<< Start < Prev 451 452 453 454 455 456 457 458 459 460 Next > End >>

Page 459 of 4210

Share |

Empowering dialysis users and caregivers

Search for dialysis centres here

Jobs in dialysis

Dialysis travel

Dialysis information

Translate Global Dialysis

Dialysis centre search LOGIN HERE

Resources